Cite
MLA Citation
Ali Bazarbachi et al.. “Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party1.” Cancer, vol. 125, no. 1, 2019, pp. 90–98. http://access.bl.uk/ark:/81055/vdc_100076295739.0x000063